WO2012086991A2 - Light therapy apparatus and method for controlling same - Google Patents

Light therapy apparatus and method for controlling same Download PDF

Info

Publication number
WO2012086991A2
WO2012086991A2 PCT/KR2011/009832 KR2011009832W WO2012086991A2 WO 2012086991 A2 WO2012086991 A2 WO 2012086991A2 KR 2011009832 W KR2011009832 W KR 2011009832W WO 2012086991 A2 WO2012086991 A2 WO 2012086991A2
Authority
WO
WIPO (PCT)
Prior art keywords
light
light source
irradiating
treatment
wavelength
Prior art date
Application number
PCT/KR2011/009832
Other languages
French (fr)
Korean (ko)
Other versions
WO2012086991A3 (en
Inventor
황해령
글렌 칼더헤드로버트
하태호
Original Assignee
(주)루트로닉
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)루트로닉 filed Critical (주)루트로닉
Publication of WO2012086991A2 publication Critical patent/WO2012086991A2/en
Publication of WO2012086991A3 publication Critical patent/WO2012086991A3/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0635Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0642Irradiating part of the body at a certain distance

Definitions

  • the present invention relates to a light therapy apparatus for treating a treatment site of a patient using a plurality of light sources and a control method thereof.
  • a product using a laser as a light source is generally widely used.
  • Lasers in various wavelengths including Nd: YAG laser, KTP laser, ER: YAG laser, CO2 laser, Ho: YAG laser, ruby laser, and alexandrite laser, are used. It is widely applied to.
  • the laser light treatment device is suitable for treating a treatment area of a local area, and there is a limitation in treating a treatment area of a large area. Therefore, in recent years, phototherapy apparatuses using other kinds of light sources such as LEDs have appeared, and Korean Patent Laid-Open Publication No. 2008-0092068 also discloses a phototherapy apparatus using LEDs.
  • the present invention is to provide a light therapy device that can improve the therapeutic effect even when using a light source with a weak light output to solve the above problems.
  • the object of the present invention described above comprises at least one plate and a plurality of first and second light sources provided on the plate and irradiating light to a treatment site of a patient, wherein the first and second light sources It can be achieved by a phototherapy device, characterized in that for irradiating light of different wavelengths.
  • the first light source may be irradiated with light of a wavelength lower than the skin light penetration of the second light source, specifically, the first light source is irradiated with light of the wavelength of the visible region, the second light source is a near infrared region Light of wavelength can be irradiated.
  • the first light source may be controlled to irradiate light with an output lower than the second light source, and specifically, the first light source may be controlled to irradiate light with an output of 10% or less than the second light source.
  • the apparatus may further include a controller configured to independently control flickering of the first light source and the second light source, wherein the controller controls the first light source to light up and irradiate light before the second light source emits light. Can be.
  • the controller may control the first light source to emit light while the second light source emits light.
  • the phototherapy apparatus includes the plurality of first light sources and the second light sources so as to form at least one row on the plate, and the rows formed by the first light sources are interposed between the rows formed by the second light sources. Can be arranged.
  • the object of the present invention is a method of controlling a phototherapy device having a plurality of LED light source, the step of driving a first light source for irradiating light having a wavelength of the visible light region, after irradiating the first light source It can also be achieved by a control method of a phototherapy device comprising driving a second light source for irradiating light having a wavelength in the near infrared region.
  • the present invention it is possible to improve the therapeutic effect by performing the preliminary treatment and the present treatment using two or more light sources having different skin penetration depths.
  • FIG. 1 is a perspective view showing a light therapy apparatus according to an embodiment of the present invention
  • FIG. 2 is a plan view illustrating a bottom surface of the light irradiation part of FIG. 1;
  • 3 is a graph showing the skin permeability according to the wavelength of light
  • FIG. 4 is a cross-sectional view showing a state in which one light source irradiates light
  • FIG. 5 is a cross-sectional view illustrating a state in which a plurality of light sources irradiate light
  • FIG. 6 is a flowchart illustrating a method of controlling the phototherapy device according to the present embodiment
  • FIG. 7 is a schematic diagram representing a preliminary treatment step in the control method of the phototherapy device according to the present embodiment
  • FIG. 8 is a schematic diagram representing the present treatment step of the control method of the phototherapy device according to the present embodiment.
  • the phototherapy apparatus 1 is a perspective view showing a light treatment device according to an embodiment of the present invention.
  • the phototherapy apparatus 1 includes a main body 10, a support 20, and a light emitter 100.
  • the main body 10 includes a power supply unit (not shown) capable of receiving power from the outside.
  • a control panel 30 for manipulating the driving contents of the phototherapy device 1 and a display 40 for displaying the same to a user may be installed on the outer surface of the main body 10.
  • a control unit (not shown) for controlling the light irradiation unit 100 in accordance with an input signal input through the control panel 30 is provided inside the main body 10.
  • the support unit 20 includes a cable (not shown) for supplying power to the light irradiation unit 100 from the power supply unit of the main body 10 and a signal line (not shown) for transmitting a control signal of the control unit to the light irradiation unit 100.
  • the support unit 20 may be configured to adjust the position of the light irradiation unit according to the treatment position of the patient. It may be configured to adjust the position by using a connecting structure such as a hinge structure, or may be changed by using a flexible material.
  • the light irradiation unit 100 is supported by the support unit 20 to irradiate light to the treatment area of the patient.
  • the light irradiator 100 includes a plurality of light sources 120 for irradiating light and a plate 110 on which the plurality of light sources 120 are installed.
  • the light irradiation unit 100 is configured by using five plates 110. At this time, each plate 110 is disposed to be inclined with an adjacent plate 110 by a predetermined angle to form an inclined surface. Therefore, while the plurality of plates 110 are arranged in a shape surrounding the treatment area of the patient, it is possible to evenly irradiate light. However, it is also possible to configure the light irradiation unit using one plate according to the therapeutic use.
  • the light irradiation unit 100 is configured to include at least two kinds of light sources for irradiating light of different wavelengths.
  • Light has different reaction characteristics in the tissues of the human body depending on the wavelength. Therefore, the present invention can improve the therapeutic effect by using light of two or more kinds of wavelengths.
  • the light source of the light irradiation unit 100 may use a light source for irradiating light having a monochromatic wavelength characteristic.
  • a light source for irradiating light having a monochromatic wavelength characteristic As an example, it is also possible to use a laser diode having a single color characteristic. In this embodiment, however, an LED module having a wide irradiation angle is used so that light can be evenly applied to a wide treatment area of a patient.
  • LED modules have also been introduced with improved wavelength characteristics, and these LED modules have wavelength characteristics substantially close to monochromatic, so that when irradiated to the human body, the response characteristics of the corresponding wavelengths can be sufficiently induced.
  • FIG. 2 is a plan view illustrating the bottom of the light irradiation part of FIG. 1.
  • the light irradiation part of the present embodiment includes a plurality of first light sources 121 and a plurality of second light sources 122.
  • the first light source 121 and the second light source 122 irradiate light of different wavelengths.
  • the first light source 121 may use light having a low skin permeability
  • the second light source 122 may use light having a good skin permeability. Therefore, the selective treatment according to the depth of the skin is possible by using the phototherapy device (1).
  • FIG. 3 is a graph showing skin permeability according to the wavelength of light. As shown in FIG. 3, light in a visible region having a wavelength of 600 nm or less has a high optical density and thus has low skin permeability, and light in a near infrared region having a wavelength of 750 nm or more has a low optical density and has a skin permeability. great.
  • the first light source 121 may be configured to irradiate first light having a wavelength of 600 nm or less, and the second light source 122 may be configured to irradiate second light having a wavelength of 750 nm or more.
  • the first light source 121 is configured to irradiate yellow light having a wavelength adjacent to 590 nm, and the second light source 122 is configured to irradiate near infrared light having a wavelength adjacent to 830 nm.
  • light having a wavelength of 830 nm irradiated from the second light source 122 penetrates deep into the tissue of the human body, thereby causing macrophages, neutrophils, mast cells, and fibroblasts. Selectively increases the action potential of skin cells involved in wound healing, including back.
  • the blood flow of axial pattern flap increases, thereby significantly improving the survival of flap and genetically responsible for osteoblast activation. To improve the genetic mechanism.
  • light at 830 nm wavelength is effective in treating various recalcitrant ulcers, treating accidental and iatrogenic wounds including burns, and osteointegration such as osseous implants. And successful effects on photorejuvenation of aging skin.
  • the depth of 590 nm wavelength irradiated from the first light source 121 is substantially limited to the epidermis (epidermis), and in some cases the epidermis-dermal junction (DEJ, It may affect the dermal-epidermal junction and the top layer of the adjacent dermis.
  • the light of the 590nm wavelength is irradiated with a low level of light output, keratinocytes, Merkel cells, Langerhans cells, etc. located in the epidermis are activated.
  • keratinocytes When keratinocytes are activated, they can instantly synthesize cell secretions such as various types of cytokines. These cell secreting substances include substances involved in inflammatory healing, and they can penetrate into the dermis through epidermal-dermal junctions to activate fibroblasts of the dermis. This process can contribute to treating wounds and restoring aged skin.
  • Merkel cells when activated, Merkel cells play a role as a sensory organ as well as a neuroendocrine system and secrete neuropeptides and neurotransmitters to relieve pain.
  • light having a wavelength of 590 nm is irradiated to the epidermis of the patient to induce cell secretion and neurotransmitter to be provided to the dermis, so that the cells located inside the dermis can be easily activated during the phototherapy. You can see the effect of conditioning.
  • the first light source 121 irradiates light of 590 nm wavelength first
  • the second light source 122 irradiates light of 830 nm wavelength, thereby treating the first light source 121.
  • the second light source 122 may be irradiated to operate to perform a substantial treatment. In this case, there is an advantage of not only inducing the immediate treatment mechanism to proceed, but also improving the treatment effect.
  • phototherapy may be performed by simultaneously irradiating the first light source 121 and the second light source 122 to the treatment site of the patient.
  • the first light source 121 and the second light source 122 are simultaneously irradiated. Even in the dermis, there is no fear that a phenomenon such as interference may occur.
  • the first light source 121 continuously activates the cells located in the epidermis to continuously secrete various delivery materials to the dermis during the phototherapy, thereby improving the therapeutic effect.
  • the first light source 121 and the second light source 122 of the light irradiation unit 100 are installed on the bottom surface of the plate 110.
  • the pattern in which the first light source 121 and the second light source 122 are installed may be variously configured.
  • the first light source 121 and the second light source 122 may be arranged to form at least one column.
  • the first light source 121 forms two rows and the second light source 122 forms ten rows in one plate 110 (see FIG. 2).
  • the heat formed by the first light source 121 may be disposed to be interposed between and enclosed by the rows in which the second light source 122 is formed.
  • FIG. 4 is a cross-sectional view showing one light source irradiating light
  • FIG. 5 is a cross-sectional view showing a plurality of light sources irradiating light.
  • the first light source 121 and the second light source 122 are configured using an LED element.
  • the light source 120 may be configured to spread within a range of a predetermined angle in the light irradiation direction so that the treatment area of the patient can be evenly irradiated. Therefore, an LED element having a light irradiation angle within a range of 10 ° to 120 ° may be used.
  • the irradiation angle of the light source may be adjusted in consideration of the distance d to the point where the treatment site is located and the distance between the light sources. You can decide.
  • a curved reflector (not shown) made of a material having excellent reflectivity may be installed on the rear side of the light source so that light irradiated from the light source may be irradiated to the treatment area of the patient.
  • the intensity of light irradiated onto the treatment part may be different according to the distance between the light source 120 and the treatment part. As shown in FIG. 4, as the distance from the light source 120 increases, the irradiation area increases to approximate the square of the distance from the light source, and the intensity of the irradiated light decreases approximately in inverse proportion to the square of the distance. Therefore, the output intensity of the light source 120 may be determined in consideration of the distance between the light source and the treatment site during light treatment.
  • the first light source 121 plays a role of preconditioning the treatment site during phototherapy, the first light source 121 is irradiated with very low energy.
  • the second light source 122 since the second light source 122 is used to perform a substantial phototherapy, the second light source 122 is irradiated with energy having a higher intensity than that of the first light source 121.
  • the second light source 122 may be configured such that the energy irradiated per unit area of the treatment area is approximately 10 to 100 times larger than the first light source 121.
  • the first light source 121 irradiates light at an intensity of 1 to 10 mJ / cm 2 per second
  • the second light source 122 is configured to irradiate light at an intensity of 50 to 500 mJ / cm 2 per second.
  • the first light source may emit light at an intensity of 2 mJ / cm 2 per second and the second light source at an intensity of 100 mJ / cm 2 per second.
  • this may of course be changed and applied according to the treatment target and treatment contents as an example.
  • the difference in the irradiation intensity of the first light source 121 and the second light source 122 may also be controlled by the irradiation method of the light source.
  • the second light source 122 may be controlled to irradiate light while blinking at a predetermined period, compared to irradiating continuous light having a predetermined intensity in a lit state.
  • the light irradiation unit 100 is preferably configured to independently control the flashing of the first light source 121 and the second light source 122.
  • the first light source 121 is configured to be evenly irradiated throughout the treatment area with low intensity. Therefore, the interval between the rows formed by the first light source 121 is preferably designed to allow the light of the first light source 121 to irradiate the entire treatment area. That is, the area irradiated to the treatment site by the first light source (121a of FIG. 2) forming one row is configured to overlap at the boundary portion with the area irradiated by the first light source (121b of FIG. 2) forming the adjacent row. Can be.
  • the second light source 122 is densely disposed compared to the first light source 121, as shown in FIG. 5, the second light source 122 is irradiated from the plurality of second light sources 122 at one position of the treatment site. . Accordingly, the second light source 122 may irradiate light with a relatively high intensity as compared with the first light source 121, and may further provide high energy to the treatment site, such as by irradiating light using a laser. have.
  • the phototherapy apparatus 1 includes a first light source 121 and a second light source 122 having different skin permeability, and the first light source 121 and the second light source ( The irradiation pattern and irradiation intensity of 122) are configured differently. Therefore, by using the characteristics of the light therapy at the time of the light treatment using the wavelength characteristics of the pre-treatment step and the main treatment step by progress, it is possible to improve the effect of the light therapy.
  • a phototherapy apparatus using two kinds of light sources has been described as an example, but this is only an example, and the phototherapy apparatus is configured using three or more kinds of light sources so that light of various wavelengths can be irradiated. It is also possible.
  • FIG. 6 is a flowchart illustrating a method of controlling the phototherapy device according to the present embodiment.
  • the driving of the phototherapy apparatus is started with the part of the patient to be treated located under the light irradiation part.
  • the phototherapy apparatus performs a preliminary treatment step of preconditioning the treatment area of the patient (S10).
  • This step may proceed by selectively driving the first light source having the wavelength of 590 nm as described above.
  • the plurality of first light sources 121 may irradiate light in a manner of blinking for a predetermined time depending on the position.
  • the light irradiation pattern of the preliminary treatment step will be described in detail with reference to FIG. 7.
  • Figure 7 is a schematic diagram representing a preliminary treatment step of the control method of the phototherapy device according to the present embodiment.
  • the light irradiation part includes five plates.
  • two rows formed by the first light source 121 are disposed in each of two plates, and a total of ten first light sources are formed.
  • the control unit controls to sequentially blink each column formed by the first light source 121.
  • the controller may control to irradiate light for 1 second from the leftmost column during the present step (FIG. 7 shows a flashing pattern made up to 5 seconds. has exist).
  • the treatment area is examined for 10 seconds while blinking from the leftmost column to the rightmost column.
  • the first light source is sequentially controlled to blink for 60 seconds in a manner of repeating the reciprocation from left to right and again from right to left.
  • the epidermal tissue of the treatment site may be activated to precondition for the present treatment.
  • the controller drives the second light source 122 to proceed with the main treatment process (S30). At this time, the second light source 122 irradiates the treatment area of the patient, which has been preconditioned, with light having a high intensity of 830 nm.
  • FIG. 8 is a schematic diagram representing the present treatment step of the control method of the phototherapy device according to the present embodiment. As shown in FIG. 8, in this step, the controller controls the second light source 122 to be turned on for a predetermined time, thereby continuously irradiating light to the treatment area of the patient.
  • This step can proceed over 9 minutes, during which the treatment site is irradiated with 54 J / cm 2 of light.
  • the treatment proceeds as the dermal tissue at the treatment site is activated.
  • the treatment step is performed in the state in which the tissues of the activated epidermal layer are activated while secreting various secretory substances while performing the preliminary treatment step, the treatment mechanism can be rapidly progressed, and the therapeutic effect can also be improved.
  • the treatment step not only the second light source 122 but also the first light source 121 may be controlled to be irradiated to the treatment site.
  • the first light source 121 and the second light source 122 irradiate light having different skin penetration depths, there is no fear that light interference or the like may occur in the dermis even if two types of light are irradiated.
  • the tissue of the epidermal layer is continuously activated even during the actual treatment mechanism in the dermal layer, it may advantageously work to improve the therapeutic effect.
  • FIG. 8 illustrates a pattern in which all of the first light sources are turned on in the treatment step. However, similarly to the preliminary treatment step, each of the heat sources may be controlled to flash sequentially.
  • the controller terminates the control of the phototherapy device by turning off the first light source and the second light source (S50).
  • control of the phototherapy device may be performed in various ways according to a user's manipulation or mode switching through the control panel.
  • two or more light sources having different skin permeability may be used to improve the effect of phototherapy by performing the preliminary treatment step and the present treatment step.
  • the above-described embodiment is not limited to the present invention as an example for explaining the technical features of the present invention, it will be understood that it can be carried out in various modifications according to the treatment target and purpose.

Abstract

The present invention relates to a light therapy apparatus which treats a treatment body part of a patient using a plurality of light sources, and to a method for controlling the same. The light therapy apparatus comprises: at least one plate; and a plurality of first light sources and second light sources arranged in the plate to irradiate light to the treatment body part of the patient. The first light sources and the second light sources irradiate light of different wavelengths.

Description

광 치료장치 및 이의 제어방법Phototherapy apparatus and control method thereof
본 발명은 다수개의 광원을 이용하여 환자의 치료 부위를 치료하는 광 치료장치 및 이의 제어방법에 관한 것이다.The present invention relates to a light therapy apparatus for treating a treatment site of a patient using a plurality of light sources and a control method thereof.
최근 들어 인체에 광을 조사하여, 인체 조직에 흡수되는 광 에너지에 의해 조직의 상태를 변화시키는 방식으로 치료하는 기술이 널리 적용되고 있다.In recent years, the technique of irradiating light to the human body and treating in a manner of changing the state of the tissue by the light energy absorbed by human tissue has been widely applied.
이러한 광을 이용한 치료 장치는 일반적으로 레이저를 광원으로 이용하는 제품이 널리 이용되고 있다. Nd:YAG 레이저, KTP 레이저, ER:YAG 레이저, CO2 레이저, Ho:YAG 레이저, 루비레이저, 알렉산드라이트 레이저 등 다양한 파장대역의 레이저가 이용되고 있으며, 제모, 피부 관리 등의 용도부터 외과 및 내과 수술 장치에까지 널리 적용되고 있다.As a treatment apparatus using such light, a product using a laser as a light source is generally widely used. Lasers in various wavelengths, including Nd: YAG laser, KTP laser, ER: YAG laser, CO2 laser, Ho: YAG laser, ruby laser, and alexandrite laser, are used. It is widely applied to.
다만, 레이저를 이용하는 광 치료장치는 국소 면적의 치료 부위를 치료하는데 적합하며, 넓은 면적의 치료 부위를 치료하는데에는 한계가 있다. 따라서, 최근 들어 엘이디 등의 다른 종류의 광원을 이용하는 광 치료장치가 등장하고 있으며, 한국특허공개공보 2008-0092068 또한 엘이디를 이용한 광 치료장치를 개시하고 있다.However, the laser light treatment device is suitable for treating a treatment area of a local area, and there is a limitation in treating a treatment area of a large area. Therefore, in recent years, phototherapy apparatuses using other kinds of light sources such as LEDs have appeared, and Korean Patent Laid-Open Publication No. 2008-0092068 also discloses a phototherapy apparatus using LEDs.
다만, 레이저 이외의 광원을 이용하는 경우 광원으로부터 치료부위에 조사되는 광 에너지가 약하기 때문에, 종래의 레이저를 이용하는 경우에 비해 치료 효과가 떨어지는 문제가 있었다.However, when a light source other than a laser is used, the light energy irradiated from the light source to the treatment site is weak, and thus there is a problem that the therapeutic effect is lower than that of the conventional laser.
본 발명은 상기한 문제점을 해결하기 위해, 광 출력이 약한 광원을 이용하는 경우에도 치료 효과를 향상시킬 수 있는 광 치료장치를 제공하기 위함이다.The present invention is to provide a light therapy device that can improve the therapeutic effect even when using a light source with a weak light output to solve the above problems.
상기한 본 발명의 목적은, 적어도 하나의 플레이트 그리고 상기 플레이트에 구비되며 환자의 치료 부위로 광을 조사하는 다수개의 제1 광원 및 제2 광원을 포함하고, 상기 제1 광원 및 상기 제2 광원은 서로 다른 파장의 광을 조사하는 것을 특징으로 하는 광 치료장치에 의해 달성될 수 있다.The object of the present invention described above comprises at least one plate and a plurality of first and second light sources provided on the plate and irradiating light to a treatment site of a patient, wherein the first and second light sources It can be achieved by a phototherapy device, characterized in that for irradiating light of different wavelengths.
여기서, 상기 제1 광원은 상기 제2 광원보다 피부 침투성이 낮은 파장의 광을 조사할 수 있으며, 구체적으로 상기 제1 광원은 가시광 영역의 파장의 광을 조사하고, 상기 제2 광원은 근적외선 영역의 파장의 광을 조사할 수 있다.Here, the first light source may be irradiated with light of a wavelength lower than the skin light penetration of the second light source, specifically, the first light source is irradiated with light of the wavelength of the visible region, the second light source is a near infrared region Light of wavelength can be irradiated.
이때, 상기 제1 광원은 상기 제2 광원보다 낮은 출력으로 광을 조사하도록 제어될 수 있으며, 구체적으로 상기 제1 광원은 상기 제2 광원대비 10% 이하의 출력으로 광을 조사하도록 제어될 수 있다.In this case, the first light source may be controlled to irradiate light with an output lower than the second light source, and specifically, the first light source may be controlled to irradiate light with an output of 10% or less than the second light source. .
여기서, 상기 제1 광원 및 상기 제2 광원의 점멸을 독립적으로 제어하는 제어부를 더 포함하고, 상기 제어부는 상기 제2 광원이 광을 조사하기 이전에 상기 제1 광원을 점등하여 광을 조사하도록 제어될 수 있다.The apparatus may further include a controller configured to independently control flickering of the first light source and the second light source, wherein the controller controls the first light source to light up and irradiate light before the second light source emits light. Can be.
그리고, 상기 제어부는 상기 제2 광원이 광을 조사하는 동안 제1 광원도 광을 조사하도록 제어할 수 있다.The controller may control the first light source to emit light while the second light source emits light.
이러한 광치료장치는 상기 다수개의 제1 광원 및 제2 광원은 상기 플레이트에 각각 적어도 하나의 열을 형성하도록 구비되고, 상기 제1 광원이 형성하는 열은 상기 제2 광원이 형성하는 열 사이에 개재되도록 배치될 수 있다.The phototherapy apparatus includes the plurality of first light sources and the second light sources so as to form at least one row on the plate, and the rows formed by the first light sources are interposed between the rows formed by the second light sources. Can be arranged.
한편, 상기한 본 발명의 목적은 다수개의 엘이디 광원을 구비하는 광 치료장치의 제어방법에 있어서, 가시광 영역의 파장을 갖는 광을 조사하는 제1 광원을 구동하는 단계, 상기 제1 광원을 조사한 후 근적외선 영역의 파장을 갖는 광을 조사하는 제2 광원을 구동하는 단계를 포함하는 광 치료장치의 제어방법에 의해서도 달성될 수 있다.On the other hand, the object of the present invention is a method of controlling a phototherapy device having a plurality of LED light source, the step of driving a first light source for irradiating light having a wavelength of the visible light region, after irradiating the first light source It can also be achieved by a control method of a phototherapy device comprising driving a second light source for irradiating light having a wavelength in the near infrared region.
본 발명에 의할 경우 피부 침투 깊이가 상이한 두 종류 이상의 광원을 이용하여 예비 치료 및 본 치료를 진행함으로써 치료 효과를 개선시키는 것이 가능하다.According to the present invention, it is possible to improve the therapeutic effect by performing the preliminary treatment and the present treatment using two or more light sources having different skin penetration depths.
도 1은 본 발명의 일 실시예에 따른 광 치료장치를 도시한 사시도,1 is a perspective view showing a light therapy apparatus according to an embodiment of the present invention,
도 2는 도 1의 광 조사부의 저면을 도시한 평면도,FIG. 2 is a plan view illustrating a bottom surface of the light irradiation part of FIG. 1;
도 3은 광의 파장에 따른 피부 침투성을 도시한 그래프,3 is a graph showing the skin permeability according to the wavelength of light,
도 4는 광 조사부의 하나의 광원이 광을 조사하는 모습을 도시한 단면도,4 is a cross-sectional view showing a state in which one light source irradiates light;
도 5는 광 조사부의 다수개의 광원이 광을 조사하는 모습을 도시한 단면도,5 is a cross-sectional view illustrating a state in which a plurality of light sources irradiate light;
도 6은 본 실시예에 따른 광 치료장치의 제어방법을 도시한 순서도,6 is a flowchart illustrating a method of controlling the phototherapy device according to the present embodiment;
도 7은 본 실시예에 따른 광 치료장치의 제어방법 중 예비 치료 단계를 도식적으로 표현한 개략도이고,7 is a schematic diagram representing a preliminary treatment step in the control method of the phototherapy device according to the present embodiment,
도 8은 본 실시예에 따른 광 치료장치의 제어방법 중 본 치료단계를 도식적으로 표현한 개략도이다.8 is a schematic diagram representing the present treatment step of the control method of the phototherapy device according to the present embodiment.
이하에서는 도면을 참고하여 본 발명의 실시예에 다른 광 치료장치 및 이의 제어방법에 대해 구체적으로 설명한다. 아래의 설명에서 각 구성요소의 위치관계는 도면을 기준으로 설명함을 원칙으로 한다. 그리고 도면은 설명의 편의를 위해 발명의 구조를 단순화하거나 필요할 경우 과장하여 표시될 수 있다. 다만, 이하의 설명은 발명의 이해를 돕기 위해 단순화된 일 예를 설명하는 것이며, 본 발명이 이에 한정되는 것은 아니다. 이 이외에도 추가적인 구성요소를 부가하거나, 변경 또는 생략하여 변형 실시할 수 있음은 물론이다.Hereinafter, with reference to the drawings will be described in detail with respect to the phototherapy device and its control method according to an embodiment of the present invention. In the following description, the positional relationship of each component should be explained based on the drawings. In addition, the drawings may be displayed by simplifying the structure of the invention or by exaggerating if necessary for the convenience of description. However, the following description is to illustrate a simplified example to help the understanding of the invention, the present invention is not limited thereto. In addition to this, additional components may be added, changed or omitted to perform the modification.
도 1은 본 발명의 일 실시예에 따른 광 치료장치를 도시한 사시도이다. 도 1에 도시된 바와 같이, 본 실시예에 따른 광 치료장치(1)는 본체(10), 지지부(20) 및 광 조사부(100)를 포함하여 구성된다.1 is a perspective view showing a light treatment device according to an embodiment of the present invention. As shown in FIG. 1, the phototherapy apparatus 1 according to the present exemplary embodiment includes a main body 10, a support 20, and a light emitter 100.
본체(10)는 외부로부터 전원을 공급받을 수 있는 전원 공급부(미도시)를 구비한다. 본체(10)의 외면에는 광 치료장치(1)의 구동 내용을 조작하기 위한 컨트롤 패널(control panel)(30) 및 이를 사용자에게 표시하는 디스플레이(display)(40)가 설치될 수 있다. 그리고, 본체(10)의 내측에는 컨트롤 패널(30)을 통해 입력되는 입력 신호에 따라 광 조사부(100)를 제어하는 제어부(미도시)가 구비된다.The main body 10 includes a power supply unit (not shown) capable of receiving power from the outside. A control panel 30 for manipulating the driving contents of the phototherapy device 1 and a display 40 for displaying the same to a user may be installed on the outer surface of the main body 10. In addition, a control unit (not shown) for controlling the light irradiation unit 100 in accordance with an input signal input through the control panel 30 is provided inside the main body 10.
본체(10)의 일측에는 광 조사부(100)를 지지하는 지지부(20)가 형성된다. 지지부(20)는 본체(10)의 전원 공급부로부터 광 조사부(100)에 전원을 공급하는 케이블(미도시) 및 제어부의 제어 신호를 광 조사부(100)로 전달하는 신호선(미도시) 등이 내장 설치된다. 그리고, 지지부(20)는 환자의 치료위치에 따라 광 조사부의 위치를 조절할 수 있도록 구성될 수 있다. 힌지 구조 등의 연결 구조를 이용하여 위치를 조절할 수 있도록 구성할 수도 있고, 플렉서블한 재질을 이용하여 위치를 변경할 수도 있다.One side of the main body 10 is formed with a support 20 for supporting the light irradiation unit 100. The support unit 20 includes a cable (not shown) for supplying power to the light irradiation unit 100 from the power supply unit of the main body 10 and a signal line (not shown) for transmitting a control signal of the control unit to the light irradiation unit 100. Is installed. In addition, the support unit 20 may be configured to adjust the position of the light irradiation unit according to the treatment position of the patient. It may be configured to adjust the position by using a connecting structure such as a hinge structure, or may be changed by using a flexible material.
광 조사부(100)는 지지부(20)에 의해 지지되어 환자의 치료부위로 광을 조사한다. 광 조사부(100)는 광을 조사하는 다수개의 광원(120) 및 상기 다수개의 광원(120)이 설치되는 플레이트(110)를 포함한다.The light irradiation unit 100 is supported by the support unit 20 to irradiate light to the treatment area of the patient. The light irradiator 100 includes a plurality of light sources 120 for irradiating light and a plate 110 on which the plurality of light sources 120 are installed.
본 실시예에서는 도 1에 도시된 바와 같이, 다섯 개의 플레이트(110)를 이용하여 광 조사부(100)를 구성한다. 이때, 각각의 플레이트(110)는 인접한 플레이트(110)와 소정 각도만큼 기울어져 경사면을 형성하도록 배치된다. 따라서, 다수개의 플레이트(110)가 환자의 치료부위를 둘러싸는 형태로 배치되면서, 광을 고르게 조사할 수 있다. 다만, 치료 용도에 따라 하나의 플레이트를 이용하여 광 조사부를 구성하는 것도 가능하다.In this embodiment, as shown in FIG. 1, the light irradiation unit 100 is configured by using five plates 110. At this time, each plate 110 is disposed to be inclined with an adjacent plate 110 by a predetermined angle to form an inclined surface. Therefore, while the plurality of plates 110 are arranged in a shape surrounding the treatment area of the patient, it is possible to evenly irradiate light. However, it is also possible to configure the light irradiation unit using one plate according to the therapeutic use.
한편, 광 조사부(100)는 서로 다른 파장의 광을 조사하는 적어도 두 종류 이상의 광원을 포함하여 구성된다. 광은 파장에 따라 인체의 조직에서 상이한 반응 특성을 갖는다. 따라서, 본 발명은 두 종류 이상의 파장의 광을 이용하여 치료 효과를 개선할 수 있다.On the other hand, the light irradiation unit 100 is configured to include at least two kinds of light sources for irradiating light of different wavelengths. Light has different reaction characteristics in the tissues of the human body depending on the wavelength. Therefore, the present invention can improve the therapeutic effect by using light of two or more kinds of wavelengths.
본 발명에 따른 광 조사부(100)의 광원은 단색성의 파장 특성을 갖는 광을 조사하는 광원을 이용할 수 있다. 일예로, 단색 특성을 갖는 레이저 다이오드를 이용하는 것도 가능하다. 다만, 본 실시예에서는 환자의 넓은 치료부위에 고르게 광을 조사할 수 있도록 넓은 조사각을 갖는 엘이디(LED) 모듈을 이용한다. 최근 들어, 엘이디 모듈도 파장 특성이 개선된 제품이 출시되고 있으며, 이러한 엘이디 모듈은 실질적으로 단색성에 가까운 파장 특성을 가지므로, 인체에 조사되면 해당 파장의 반응 특성을 충분히 유도할 수 있다.The light source of the light irradiation unit 100 according to the present invention may use a light source for irradiating light having a monochromatic wavelength characteristic. As an example, it is also possible to use a laser diode having a single color characteristic. In this embodiment, however, an LED module having a wide irradiation angle is used so that light can be evenly applied to a wide treatment area of a patient. Recently, LED modules have also been introduced with improved wavelength characteristics, and these LED modules have wavelength characteristics substantially close to monochromatic, so that when irradiated to the human body, the response characteristics of the corresponding wavelengths can be sufficiently induced.
이하에서는 도 2를 참조하여 본 실시예에 따른 광 조사부의 광원에 대해 구체적으로 설명하도록 한다. Hereinafter, a light source of the light irradiation part according to the present embodiment will be described in detail with reference to FIG. 2.
도 2는 도 1의 광 조사부의 저면을 도시한 평면도이다. 도 2에 도시된 바와 같이, 본 실시예의 광 조사부는 다수개의 제1 광원(121) 및 다수개의 제2 광원(122)을 포함하여 구성된다. 여기서 제1 광원(121) 및 제2 광원(122)은 서로 상이한 파장의 광을 조사한다.FIG. 2 is a plan view illustrating the bottom of the light irradiation part of FIG. 1. As shown in FIG. 2, the light irradiation part of the present embodiment includes a plurality of first light sources 121 and a plurality of second light sources 122. Here, the first light source 121 and the second light source 122 irradiate light of different wavelengths.
이때, 제1 광원(121)은 피부 침투성이 낮은 파장의 광을 이용하고, 제2 광원(122)은 피부 침투성이 우수한 파장의 광을 이용할 수 있다. 따라서, 광 치료장치(1)를 이용하여 피부의 깊이에 따른 선택적인 치료가 가능하다.In this case, the first light source 121 may use light having a low skin permeability, and the second light source 122 may use light having a good skin permeability. Therefore, the selective treatment according to the depth of the skin is possible by using the phototherapy device (1).
도 3은 광의 파장에 따른 피부 침투성을 도시한 그래프이다. 도 3에 도시된 바와 같이, 파장이 600nm이하인 가시광 영역의 광은 광 밀도(optical density)가 높아 피부 침투성이 낮고, 파장이 750nm 이상인 근적외선 영역의 광은 광 밀도(optical density)가 낮아 피부 침투성이 우수하다.3 is a graph showing skin permeability according to the wavelength of light. As shown in FIG. 3, light in a visible region having a wavelength of 600 nm or less has a high optical density and thus has low skin permeability, and light in a near infrared region having a wavelength of 750 nm or more has a low optical density and has a skin permeability. great.
따라서, 본 실시예에서는 제1 광원(121)은 600nm 이하의 파장을 갖는 제1 광을 조사하고, 제2 광원(122)은 750nm 이상의 파장을 갖는 제2 광을 조사하도록 구성할 수 있다 구체적으로, 제1 광원(121)은 590nm에 인접한 파장을 갖는 노란색의 광을 조사하고, 제2 광원(122)은 830nm에 인접한 파장을 갖는 근적외선 광을 조사하도록 구성한다.Therefore, in the present embodiment, the first light source 121 may be configured to irradiate first light having a wavelength of 600 nm or less, and the second light source 122 may be configured to irradiate second light having a wavelength of 750 nm or more. The first light source 121 is configured to irradiate yellow light having a wavelength adjacent to 590 nm, and the second light source 122 is configured to irradiate near infrared light having a wavelength adjacent to 830 nm.
여기서, 제2 광원(122)에서 조사되는 830nm 파장의 광은 인체의 조직 깊은 위치까지 침투하여, 대식세포(macrophages), 호중성 백혈구(neutrophils), 비만 세포(mast cells), 섬유아세포(fibroblast) 등을 포함하는 상처 치료에 관여하는 피부 세포의 활동전위(action potential)를 선택적으로 현저하게 증가시킨다. 그리고, 830nm 파장의 광을 조사하면 경우 축성 형태의 피판(axial pattern flap)의 혈류(blood flow)를 증가시켜, 피판의 생존의 현저하게 개선시키기며, 유전적으로도 골아세포(osteblast) 활성화를 담당하는 유전적 메커니즘을 향상시킨다. 따라서, 830nm 파장의 광은 각종 저항성 궤양(recalcitrant ulcer) 치료, 화상을 포함하는 사고성 및 의원성 장애(accidental and iatrogenic wound) 치료, 골 이식(osseous implant) 등의 골 유착(osseointegration) 등에 효과가 있고, 노화성 피부의 광학적 회복(photorejuvenation)에 성공적인 효과를 볼 수 있다.Here, light having a wavelength of 830 nm irradiated from the second light source 122 penetrates deep into the tissue of the human body, thereby causing macrophages, neutrophils, mast cells, and fibroblasts. Selectively increases the action potential of skin cells involved in wound healing, including back. In addition, when irradiated with light of 830nm wavelength, the blood flow of axial pattern flap increases, thereby significantly improving the survival of flap and genetically responsible for osteoblast activation. To improve the genetic mechanism. Thus, light at 830 nm wavelength is effective in treating various recalcitrant ulcers, treating accidental and iatrogenic wounds including burns, and osteointegration such as osseous implants. And successful effects on photorejuvenation of aging skin.
이에 비해, 제1 광원(121)에서 조사되는 590nm 파장의 광은 실질적으로 피부에 침투하여 실질적으로 영향을 미칠 수 있는 깊이는 표피(epidermis)에 한정되며, 경우에 따라 표피-진피 접합부(DEJ, dermal-epidermal junction)와 인접한 진피(dermis)의 최상층까지 영향을 미칠 수 있다. 이러한 590nm 파장의 광을 낮은 수준의 광 출력으로 조사하게 되면, 표피에 위치한 케라티노사이트(keratinocyte), 머르켈 세포(Merkel cell), 랑게르한스 세포(Langerhans cell) 등이 활성화된다.In contrast, the depth of 590 nm wavelength irradiated from the first light source 121 is substantially limited to the epidermis (epidermis), and in some cases the epidermis-dermal junction (DEJ, It may affect the dermal-epidermal junction and the top layer of the adjacent dermis. When the light of the 590nm wavelength is irradiated with a low level of light output, keratinocytes, Merkel cells, Langerhans cells, etc. located in the epidermis are activated.
케라티노사이트는 활성화되면 다양한 종류의 시토키닌(cytokine)과 같은 세포 분비물질을 즉시 합성할 수 있다. 이러한 세포 분비물질은 염증 치유에 관여하는 물질을 포함하며, 이들은 표피-진피 결합부를 통해 진피로 침투하여 진피의 섬유아세포(fibroblast)를 활성화시킬 수 있다. 이러한 과정에 의해 상처 부위를 치료하고 노화된 피부를 회복시키는데 기여할 수 있다.When keratinocytes are activated, they can instantly synthesize cell secretions such as various types of cytokines. These cell secreting substances include substances involved in inflammatory healing, and they can penetrate into the dermis through epidermal-dermal junctions to activate fibroblasts of the dermis. This process can contribute to treating wounds and restoring aged skin.
또한, 머르켈 세포도 활성화되면 감각기관으로서의 역할과 더불어 신경 내분비 시스템으로서의 역할을 수행하며, 신경 펩티드 및 신경 전달물질을 분비하여 고통을 경감시키는 역할을 수행한다.In addition, when activated, Merkel cells play a role as a sensory organ as well as a neuroendocrine system and secrete neuropeptides and neurotransmitters to relieve pain.
이와 같이, 590nm의 파장을 갖는 광은 환자의 표피에 조사되어 세포 분비물질 및 신경 전달물질 등이 진피로 제공되도록 유도하여, 광 치료를 진행함에 있어 진피 내측에 위치한 세포들이 쉽게 활성화될 수 있도록 프리컨디셔닝(preconditioning)하는 효과를 볼 수 있다.As such, light having a wavelength of 590 nm is irradiated to the epidermis of the patient to induce cell secretion and neurotransmitter to be provided to the dermis, so that the cells located inside the dermis can be easily activated during the phototherapy. You can see the effect of conditioning.
따라서, 본 실시예에 따른 광 치료장치는 제1 광원(121)이 590nm 파장의 광을 먼저 조사하고, 제2 광원(122)이 830nm 파장의 광을 조사함으로써, 제1 광원(121)이 치료 부위의 진피 조직을 프리컨디셔닝 시킨 상태에서 제2 광원(122)이 조사되어 실질적인 치료를 진행하도록 동작할 수 있다. 이 경우, 즉각적인 치료 기전이 진행되도록 유도할 뿐 아니라 치료 효과를 개선시키는 장점이 있다.Therefore, in the phototherapy device according to the present embodiment, the first light source 121 irradiates light of 590 nm wavelength first, and the second light source 122 irradiates light of 830 nm wavelength, thereby treating the first light source 121. In a state where the dermal tissue of the site is preconditioned, the second light source 122 may be irradiated to operate to perform a substantial treatment. In this case, there is an advantage of not only inducing the immediate treatment mechanism to proceed, but also improving the treatment effect.
또한, 제1 광원(121) 및 제2 광원(122)을 환자의 치료 부위에 동시에 조사하는 방식으로 광치료를 진행할 수도 있다. 전술한 바와 같이, 제1 광원(121) 및 제2 광원(122)은 피부 조사시 광이 흡수되는 위치가 각각 상이하기 때문에, 제1 광원(121)과 제2 광원(122)이 동시에 조사되는 경우에도 진피 상에서 간섭 등의 현상이 발생할 우려가 없다. 그리고, 이 경우, 광 치료가 진행되는 동안 지속적으로 제1 광원(121)이 표피에 위치한 세포들을 활성화시켜 각종 전달물질 등을 진피측으로 지속적으로 분비하도록 유도함으로써, 치료 효과를 개선시킬 수 있다. In addition, phototherapy may be performed by simultaneously irradiating the first light source 121 and the second light source 122 to the treatment site of the patient. As described above, since the positions where the light is absorbed are different from each other when the first light source 121 and the second light source 122 are irradiated with skin, the first light source 121 and the second light source 122 are simultaneously irradiated. Even in the dermis, there is no fear that a phenomenon such as interference may occur. In this case, the first light source 121 continuously activates the cells located in the epidermis to continuously secrete various delivery materials to the dermis during the phototherapy, thereby improving the therapeutic effect.
이러한 광 조사부(100)의 제1 광원(121) 및 제2 광원(122)은 플레이트(110)의 저면에 설치된다. 제1 광원(121) 및 제2 광원(122)이 설치되는 패턴은 다양하게 구성될 수 있다. 본 실시예에서는 일 예로서, 제1 광원(121) 및 제2 광원(122)이 각각 적어도 하나의 열을 형성하도록 배치할 수 있다. 구체적으로, 하나의 플레이트(110)에는 제1 광원(121)이 2개의 열을 형성하고, 제2 광원(122)이 10개의 열을 형성하도록 배치된다(도 2 참조). 그리고, 제1 광원(121)에 의해 형성된 열은 제2 광원(122)이 형성된 열들의 사이에 개재되어 그에 의해 둘러싸이도록 배치될 수 있다.The first light source 121 and the second light source 122 of the light irradiation unit 100 are installed on the bottom surface of the plate 110. The pattern in which the first light source 121 and the second light source 122 are installed may be variously configured. In this embodiment, for example, the first light source 121 and the second light source 122 may be arranged to form at least one column. Specifically, the first light source 121 forms two rows and the second light source 122 forms ten rows in one plate 110 (see FIG. 2). In addition, the heat formed by the first light source 121 may be disposed to be interposed between and enclosed by the rows in which the second light source 122 is formed.
도 4는 광 조사부의 하나의 광원이 광을 조사하는 모습을 도시한 단면도이고, 도 5는 광 조사부의 다수개의 광원이 광을 조사하는 모습을 도시한 단면도이다.4 is a cross-sectional view showing one light source irradiating light, and FIG. 5 is a cross-sectional view showing a plurality of light sources irradiating light.
전술한 바와 같이, 제1 광원(121) 및 제2 광원(122)은 엘이디 소자를 이용하여 구성된다. 이때 광원(120)은 환자의 치료 부위에 고르게 조사될 수 있도록, 광 조사 방향으로 소정 각도의 범위 내에서 퍼져나가도록 구성될 수 있다. 따라서, 10° 내지 120° 범위 내의 광 조사각을 갖는 엘이디 소자를 이용할 수 있으며, 구체적으로는 치료 부위가 위치하는 지점까지의 거리(d) 및 광원 사이의 간격 등을 고려하여 광원의 조사각을 결정할 수 있다. 또한, 도면상에는 도시되지 않았으나 광원에서 조사되는 광이 환자의 치료부위로 조사될 수 있도록, 광원의 후측에는 반사성이 우수한 재질로 이루어진 곡면 형태의 반사판(미도시)이 설치될 수도 있다.As described above, the first light source 121 and the second light source 122 are configured using an LED element. In this case, the light source 120 may be configured to spread within a range of a predetermined angle in the light irradiation direction so that the treatment area of the patient can be evenly irradiated. Therefore, an LED element having a light irradiation angle within a range of 10 ° to 120 ° may be used. Specifically, the irradiation angle of the light source may be adjusted in consideration of the distance d to the point where the treatment site is located and the distance between the light sources. You can decide. In addition, although not shown in the drawing, a curved reflector (not shown) made of a material having excellent reflectivity may be installed on the rear side of the light source so that light irradiated from the light source may be irradiated to the treatment area of the patient.
이와 같이 광원(120)은 소정의 조사각으로 광을 조사하므로, 치료부위에 조사되는 광의 세기는 광원(120)과 치료부위의 간격에 따라 상이할 수 있다. 도 4에 도시된 바와 같이, 광원(120)으로부터 거리가 멀어질수록 조사 면적은 광원으로부터 거리의 제곱에 근사하도록 증가하고, 조사되는 광의 세기는 대략적으로 상기 거리의 제곱에 반비례하여 감소한다. 따라서, 광원(120)의 출력 세기는 광 치료시 광원과 치료 부위간의 거리를 고려하여 결정될 수 있다.As such, since the light source 120 irradiates light at a predetermined irradiation angle, the intensity of light irradiated onto the treatment part may be different according to the distance between the light source 120 and the treatment part. As shown in FIG. 4, as the distance from the light source 120 increases, the irradiation area increases to approximate the square of the distance from the light source, and the intensity of the irradiated light decreases approximately in inverse proportion to the square of the distance. Therefore, the output intensity of the light source 120 may be determined in consideration of the distance between the light source and the treatment site during light treatment.
구체적으로, 제1 광원(121)은 광 치료시 치료 부위를 프리컨디셔닝하는 역할을 수행하므로 매우 낮은 강도의 에너지로 조사된다. 이에 비해, 제2 광원(122)은 실질적인 광 치료를 진행하는데 이용되므로, 제1 광원(121)에 비해 높은 강도의 에너지로 조사된다.Specifically, since the first light source 121 plays a role of preconditioning the treatment site during phototherapy, the first light source 121 is irradiated with very low energy. On the contrary, since the second light source 122 is used to perform a substantial phototherapy, the second light source 122 is irradiated with energy having a higher intensity than that of the first light source 121.
구체적으로, 제2 광원(122)은 제1 광원(121)과 비교하여, 치료 부위의 단위 면적당 조사되는 에너지가 대략 10 내지 100배 크도록 구성될 수 있다. 본 실시예에서는 제1 광원(121)은 1초당 1~10mJ/cm2의 강도로 광을 조사하고, 제2 광원(122)은 1초당 50~500mJ/cm2의 강도로 광을 조사하도록 구성하며, 더욱 구체적으로는 제1 광원은 1초당 2mJ/cm2의 강도로, 제2 광원은 1초당 100mJ/cm2의 강도로 광을 조사할 수 있다. 다만, 이는 일 예로서 치료 대상 및 치료 내용에 따라 변경하여 적용할 수 있음은 물론이다.Specifically, the second light source 122 may be configured such that the energy irradiated per unit area of the treatment area is approximately 10 to 100 times larger than the first light source 121. In the present embodiment, the first light source 121 irradiates light at an intensity of 1 to 10 mJ / cm 2 per second, and the second light source 122 is configured to irradiate light at an intensity of 50 to 500 mJ / cm 2 per second. More specifically, the first light source may emit light at an intensity of 2 mJ / cm 2 per second and the second light source at an intensity of 100 mJ / cm 2 per second. However, this may of course be changed and applied according to the treatment target and treatment contents as an example.
나아가, 제1 광원(121) 및 제2 광원(122)의 조사 강도의 차이는 광원의 조사 방식에 의해서도 제어될 수 있다. 예를 들어, 제2 광원(122)은 점등된 상태에서 소정 강도의 연속광을 조사하는 것에 비해, 제1 광원(121)은 소정 주기로 점멸하면서 광을 조사하도록 제어될 수 있다. 이때, 광 조사부(100)는 제1 광원(121) 및 제2 광원(122)의 점멸을 독립적으로 제어할 수 있도록 구성되는 것이 바람직하다.Furthermore, the difference in the irradiation intensity of the first light source 121 and the second light source 122 may also be controlled by the irradiation method of the light source. For example, the second light source 122 may be controlled to irradiate light while blinking at a predetermined period, compared to irradiating continuous light having a predetermined intensity in a lit state. At this time, the light irradiation unit 100 is preferably configured to independently control the flashing of the first light source 121 and the second light source 122.
구체적으로, 제1 광원(121)은 낮은 강도의 세기로 치료 부위 전체에 고르게 조사될 수 있도록 구성된다. 따라서, 제1 광원(121)이 형성하는 열 사이의 간격은 제1 광원(121)의 광이 치료 부위 전체를 조사할 수 있도록 설계되는 것이 바람직하다. 즉, 하나의 열을 형성하는 제1 광원(도 2의 121a)이 치료 부위에 조사하는 영역은 인접한 열을 형성하는 제1 광원(도 2의 121b)이 조사하는 영역과 경계 부분에서 중첩되도록 구성될 수 있다.Specifically, the first light source 121 is configured to be evenly irradiated throughout the treatment area with low intensity. Therefore, the interval between the rows formed by the first light source 121 is preferably designed to allow the light of the first light source 121 to irradiate the entire treatment area. That is, the area irradiated to the treatment site by the first light source (121a of FIG. 2) forming one row is configured to overlap at the boundary portion with the area irradiated by the first light source (121b of FIG. 2) forming the adjacent row. Can be.
그리고, 제2 광원(122)은 제1 광원(121)에 비해 밀집되어 배치되므로, 도 5에 도시된 바와 같이, 치료 부위의 일 위치에서는 다수개의 제2 광원(122)으로부터 중첩적으로 조사된다. 따라서, 제2 광원(122)은 제1 광원(121)과 비교하여 상대적으로 높은 강도로 광을 조사하는 것이 가능하며, 나아가 레이저를 이용하여 광을 조사한 것과 같이 치료 부위에 높은 에너지를 제공할 수 있다.In addition, since the second light source 122 is densely disposed compared to the first light source 121, as shown in FIG. 5, the second light source 122 is irradiated from the plurality of second light sources 122 at one position of the treatment site. . Accordingly, the second light source 122 may irradiate light with a relatively high intensity as compared with the first light source 121, and may further provide high energy to the treatment site, such as by irradiating light using a laser. have.
이상에서 설명한 바와 같이, 본 실시예에 따른 광 치료장치(1)는 피부 침투성이 상이한 제1 광원(121) 및 제2 광원(122)을 구비하고, 제1 광원(121) 및 제2 광원(122)의 조사 패턴 및 조사 강도를 상이하게 구성된다. 따라서, 이러한 특성을 이용하여 광 치료시 광의 파장 특성을 이용하여 예비 치료 단계 및 본 치료 단계를 구분하여 진행함으로써, 광 치료의 효과를 향상시킬 수 있다.As described above, the phototherapy apparatus 1 according to the present embodiment includes a first light source 121 and a second light source 122 having different skin permeability, and the first light source 121 and the second light source ( The irradiation pattern and irradiation intensity of 122) are configured differently. Therefore, by using the characteristics of the light therapy at the time of the light treatment using the wavelength characteristics of the pre-treatment step and the main treatment step by progress, it is possible to improve the effect of the light therapy.
다만, 본 실시예에서는 두 종류의 광원을 이용한 광 치료장치를 예를 들어 설명하였으나, 이는 일 예에 불과하며 보다 다양한 파장의 광을 조사할 수 있도록 세 종류 이상의 광원을 이용하여 광 치료장치를 구성하는 것도 가능하다.However, in the present embodiment, a phototherapy apparatus using two kinds of light sources has been described as an example, but this is only an example, and the phototherapy apparatus is configured using three or more kinds of light sources so that light of various wavelengths can be irradiated. It is also possible.
이하에서는, 도 6 내지 도 8을 이용하여 본 실시예에 따른 광 치료장치의 제어방법에 대해 설명하도록 한다.Hereinafter, a method of controlling the phototherapy apparatus according to the present embodiment will be described with reference to FIGS. 6 to 8.
도 6은 본 실시예에 따른 광 치료장치의 제어방법을 도시한 순서도이다. 우선, 치료할 환자의 부위를 광 조사부의 하측에 위치한 상태에서 광 치료장치의 구동을 시작한다.6 is a flowchart illustrating a method of controlling the phototherapy device according to the present embodiment. First, the driving of the phototherapy apparatus is started with the part of the patient to be treated located under the light irradiation part.
이때, 광 치료장치는 환자의 치료부위를 프리컨디셔닝(preconditioning)하는 예비 치료 단계를 수행한다(S10). 이 단계는 전술한 바와 같이 590nm 파장을 갖는 제1 광원을 선택적으로 구동하여 진행할 수 있다.In this case, the phototherapy apparatus performs a preliminary treatment step of preconditioning the treatment area of the patient (S10). This step may proceed by selectively driving the first light source having the wavelength of 590 nm as described above.
본 단계에서는 피부 표피의 세포만을 선택적으로 활성화시킬 수 있도록 제1 광원(121)에서 낮은 강도로 광을 조사한다. 이를 위해, 다수개의 제1 광원(121)은 위치에 따라 소정 시간씩 점멸하는 방식으로 광을 조사할 수 있다. 이하에서는 도 7을 참조하여 예비 치료 단계의 광 조사 패턴을 구체적으로 설명하도록 한다.In this step, light is irradiated with low intensity from the first light source 121 to selectively activate only the cells of the skin epidermis. To this end, the plurality of first light sources 121 may irradiate light in a manner of blinking for a predetermined time depending on the position. Hereinafter, the light irradiation pattern of the preliminary treatment step will be described in detail with reference to FIG. 7.
도 7은 본 실시예에 따른 광 치료장치의 제어방법 중 예비 치료 단계를 도식적으로 표현한 개략도이다.Figure 7 is a schematic diagram representing a preliminary treatment step of the control method of the phototherapy device according to the present embodiment.
전술한 바와 같이, 본 실시예에 따른 광 조사부는 다섯 개의 플레이트를 구비한다. 그리고 하나의 플레이트에는 제1 광원(121)이 형성하는 열이 각각 2개씩 배치되어, 총 10개의 제1 광원의 열이 형성된다. 본 단계에서 제어부는 제1 광원(121)이 형성하는 각각의 열을 순차적으로 점멸하도록 제어한다.As described above, the light irradiation part according to the present embodiment includes five plates. In addition, two rows formed by the first light source 121 are disposed in each of two plates, and a total of ten first light sources are formed. In this step, the control unit controls to sequentially blink each column formed by the first light source 121.
일 예로서, 도 7에 도시된 바와 같이, 제어부는 본 단계가 진행되는 동안 가장 좌측에 위치한 열로부터 각각 1초씩 광을 조사하도록 제어할 수 있다(도 7은 5초까지 이루어진 점멸 패턴을 도시하고 있음). 이 경우, 가장 좌측에 위치한 열로부터 가장 우측에 위치한 열까지 점멸이 이루어지면서 10초의 시간동안 치료부위를 전체적으로 조사한다.As an example, as shown in FIG. 7, the controller may control to irradiate light for 1 second from the leftmost column during the present step (FIG. 7 shows a flashing pattern made up to 5 seconds. has exist). In this case, the treatment area is examined for 10 seconds while blinking from the leftmost column to the rightmost column.
이와 같이 좌측에서 우측으로, 그리고 다시 우측에서 좌측으로 왕복하는 것을 반복하는 방식으로 60초 동안 제1 광원이 순차적으로 점멸하도록 제어된다. 본 단계를 통해 제1 광원으로부터 2mJ/cm2 정도로 낮은 강도의 광이 불연속적으로 6회에 걸쳐 조사됨에 따라 치료부위의 표피 조직을 활성화되어 본 치료를 위한 프리컨디셔닝이 이루어질 수 있다.As such, the first light source is sequentially controlled to blink for 60 seconds in a manner of repeating the reciprocation from left to right and again from right to left. In this step, as light having a low intensity of about 2 mJ / cm 2 is irradiated six times discontinuously from the first light source, the epidermal tissue of the treatment site may be activated to precondition for the present treatment.
이러한 예비 치료 단계가 종료되면(S20), 제어부는 제2 광원(122)을 구동하여 본 치료단계(main treatment process)를 진행한다(S30). 이때, 제2 광원(122)은 프리컨디셔닝이 이루어진 환자의 치료부위에 830nm 파장의 광을 높은 강도로 조사한다.When the preliminary treatment step ends (S20), the controller drives the second light source 122 to proceed with the main treatment process (S30). At this time, the second light source 122 irradiates the treatment area of the patient, which has been preconditioned, with light having a high intensity of 830 nm.
도 8은 본 실시예에 따른 광 치료장치의 제어방법 중 본 치료단계를 도식적으로 표현한 개략도이다. 도 8에 도시된 바와 같이, 본 단계에서 제어부는 제2 광원(122)이 소정 시간동안 점등된 상태를 유지하도록 제어함으로써, 환자의 치료 부위에 연속적으로 광을 조사한다.8 is a schematic diagram representing the present treatment step of the control method of the phototherapy device according to the present embodiment. As shown in FIG. 8, in this step, the controller controls the second light source 122 to be turned on for a predetermined time, thereby continuously irradiating light to the treatment area of the patient.
본 단계는 9분에 걸쳐 진행될 수 있으며, 본 단계를 수행하는 동안 치료 부위에는 54J/cm2의 광이 조사된다. 따라서, 치료 부위의 진피 조직이 활성화됨에 따라 본 치료가 진행된다. 이때, 예비 치료 단계를 수행하면서 활성화된 표피층의 조직들이 활성화되어 각종 분비 물질의 분비가 이루어진 상태에서 본 치료단계가 이루어지므로 치료 기전이 빠르게 진행될 수 있으며, 치료 효과 또한 향상될 수 있다.This step can proceed over 9 minutes, during which the treatment site is irradiated with 54 J / cm 2 of light. Thus, the treatment proceeds as the dermal tissue at the treatment site is activated. At this time, since the treatment step is performed in the state in which the tissues of the activated epidermal layer are activated while secreting various secretory substances while performing the preliminary treatment step, the treatment mechanism can be rapidly progressed, and the therapeutic effect can also be improved.
한편, 본 치료 단계에서는 제2 광원(122) 뿐 아니라 제1 광원(121) 또한 치료 부위로 조사되도록 제어될 수 있다. 앞서 설명한 바와 같이, 제1 광원(121) 및 제2 광원(122)은 각각 피부 침투 깊이가 상이한 광을 조사하므로, 두 종류의 광이 조사되더라도 진피층에서 광의 간섭 등이 현상이 발생할 우려가 없다. 그리고, 진피층에서 실질적인 치료 기전이 진행되는 동안에도 표피층의 조직이 지속적으로 활성화됨에 따라 치료 효과를 향상시키는데 유리하게 작용할 수 있다.Meanwhile, in the treatment step, not only the second light source 122 but also the first light source 121 may be controlled to be irradiated to the treatment site. As described above, since the first light source 121 and the second light source 122 irradiate light having different skin penetration depths, there is no fear that light interference or the like may occur in the dermis even if two types of light are irradiated. In addition, as the tissue of the epidermal layer is continuously activated even during the actual treatment mechanism in the dermal layer, it may advantageously work to improve the therapeutic effect.
도 8에서는 본 치료단계시 제1 광원이 모두 점등되는 패턴을 도시하고 있으나, 예비 치료 단계와 마찬가지로 각각의 열이 순차적으로 점멸하도록 제어되는 것도 가능하다.FIG. 8 illustrates a pattern in which all of the first light sources are turned on in the treatment step. However, similarly to the preliminary treatment step, each of the heat sources may be controlled to flash sequentially.
전술한 방식으로 본 치료 단계가 9분 동안 진행되면, 제어부는 제1 광원 및 제2 광원을 오프(off)시킴으로써 광 치료장치의 제어를 종료한다(S50).When the treatment step is performed for 9 minutes in the above-described manner, the controller terminates the control of the phototherapy device by turning off the first light source and the second light source (S50).
이상에서는 광 치료장치가 10분의 광치료를 진행하기 위한 제어 방법을 일 예로 설명하고 있으나, 본 발명이 이에 한정되는 것은 아니다. 컨트롤 패널을 통한 사용자의 조작 또는 모드 전환에 따라 광 치료장치의 제어는 다양한 방식으로 이루어질 수 있다.In the above described the control method for the phototherapy device to perform the phototherapy of 10 minutes as an example, but the present invention is not limited thereto. Control of the phototherapy device may be performed in various ways according to a user's manipulation or mode switching through the control panel.
이와 같이 본 발명에 의할 경우 피부 투과성이 상이한 두 개 이상의 광원을 이용하여 예비 치료 단계 및 본 치료 단계를 진행함으로써 광 치료의 효과를 향상시킬 수 있다. 다만, 전술한 실시예는 이러한 본 발명의 기술적 특징을 설명하기 위한 일 예로서 본 발명이 이에 한정되는 것은 아니며, 치료 대상 및 목적에 따라 다양하게 변경하여 실시될 수 있음을 밝혀둔다.As described above, according to the present invention, two or more light sources having different skin permeability may be used to improve the effect of phototherapy by performing the preliminary treatment step and the present treatment step. However, the above-described embodiment is not limited to the present invention as an example for explaining the technical features of the present invention, it will be understood that it can be carried out in various modifications according to the treatment target and purpose.

Claims (24)

  1. 적어도 하나의 플레이트; 그리고,At least one plate; And,
    상기 플레이트에 구비되며 환자의 치료 부위로 광을 조사하는 다수개의 제1 광원 및 제2 광원을 포함하고,A plurality of first light sources and a second light source provided on the plate to irradiate light to the treatment site of the patient;
    상기 제1 광원 및 상기 제2 광원은 서로 다른 파장의 광을 조사하는 것을 특징으로 하는 광 치료장치.And the first light source and the second light source irradiate light having different wavelengths.
  2. 제1항에 있어서,The method of claim 1,
    상기 제1 광원은 상기 제2 광원보다 피부 침투성이 낮은 파장의 광을 조사하는 것을 특징으로 하는 광 치료장치.The first light source is a light treatment device, characterized in that for irradiating light of a wavelength lower than the skin penetration property than the second light source.
  3. 제2항에 있어서,The method of claim 2,
    상기 제1 광원은 가시광 영역의 파장의 광을 조사하고, 상기 제2 광원은 근적외선 영역의 파장의 광을 조사하는 것을 특징으로 하는 광 치료장치.The first light source is irradiated with light of the wavelength of the visible light region, the second light source is a light therapy device, characterized in that for irradiating light of the wavelength of the near infrared region.
  4. 제3항에 있어서,The method of claim 3,
    상기 제1 광원은 600nm 이하의 파장의 광을 조사하고, 상기 제2 광원은 750nm 이상의 광을 조사하는 것을 특징으로 하는 광 치료장치.The first light source is irradiated with light of a wavelength of 600nm or less, the second light source is characterized in that irradiating light of 750nm or more.
  5. 제1항에 있어서,The method of claim 1,
    상기 제1 광원은 상기 제2 광원보다 낮은 출력으로 광을 조사하는 것을 특징으로 하는 광 치료장치.And the first light source irradiates light with an output lower than that of the second light source.
  6. 제5항에 있어서,The method of claim 5,
    상기 제1 광원은 상기 제2 광원대비 10% 이하의 출력으로 광을 조사하는 것을 특징으로 하는 광 치료장치The first light source is a light treatment device, characterized in that for irradiating light with an output of 10% or less than the second light source
  7. 제1항, 제2항 및 제5항 중 어느 한 항에 있어서,The method according to any one of claims 1, 2 and 5,
    상기 제1 광원 및 상기 제2 광원의 점멸을 독립적으로 제어하는 제어부를 더 포함하고, 상기 제어부는 상기 제2 광원이 광을 조사하기 이전에 상기 제1 광원을 점등하여 광을 조사하도록 제어하는 것을 특징으로 하는 광 치료장치.And a controller for independently controlling the flickering of the first light source and the second light source, wherein the controller controls the second light source to turn on the first light source to irradiate light before the second light source emits light. Light treatment device characterized in that.
  8. 제7항에 있어서,The method of claim 7, wherein
    상기 제어부는 상기 제2 광원이 광을 조사하는 동안 제1 광원도 광을 조사하도록 제어하는 것을 특징으로 하는 광 치료장치.And the controller controls the first light source to emit light while the second light source emits light.
  9. 제7항에 있어서,The method of claim 7, wherein
    상기 제1 광원은 반복적으로 점멸하는 패턴으로 광을 조사하고, 상기 제2 광원은 기 설정된 시간 동안 연속적으로 점등 상태를 유지하여 광을 조사하는 것을 특징으로 하는 광 치료장치.And the first light source irradiates light in a repeatedly blinking pattern, and the second light source continuously emits light for a predetermined time to irradiate light.
  10. 제7항에 있어서,The method of claim 7, wherein
    상기 플레이트에 구비되는 상기 제2 광원의 개수는 상기 제1 광원의 개수 보다 많은 것을 특징으로 하는 광 치료장치.And the number of the second light sources provided in the plate is greater than the number of the first light sources.
  11. 제8항에 있어서,The method of claim 8,
    상기 다수개의 제1 광원 및 제2 광원은 상기 플레이트에 각각 적어도 하나의 열을 형성하도록 구비되고, 상기 제1 광원이 형성하는 열은 상기 제2 광원이 형성하는 열 사이에 개재되도록 배치되는 것을 특징으로 하는 광 치료장치.The plurality of first light sources and second light sources are provided to form at least one row on the plate, respectively, and the rows formed by the first light sources are disposed to be interposed between the rows formed by the second light sources. Phototherapy device.
  12. 제11항에 있어서,The method of claim 11,
    상기 제1 광원 및 상기 제2 광원은 각각 엘이디 소자를 이용하여 구성되며, 상기 각각의 엘이디 소자는 10~120°의 조사각을 갖는 것을 특징으로 하는 광 치료장치.The first light source and the second light source are each configured using an LED element, each LED element is characterized in that the light treatment device having an irradiation angle of 10 ~ 120 °.
  13. 제7항에 있어서,The method of claim 7, wherein
    상기 다수개의 제1 광원 및 상기 제2 광원이 구비되는 상기 플레이트는 복수개로 구비되고, 상기 각각의 플레이트는 인접한 플레이트와 경사면을 형성하도록 배치되는 것을 특징으로 하는 광 치료장치.And a plurality of plates provided with the plurality of first light sources and the second light sources, wherein each plate is disposed to form an inclined surface with an adjacent plate.
  14. 제7항에 있어서,The method of claim 7, wherein
    상기 다수개의 제1 광원 및 상기 제2 광원이 구비되는 상기 플레이트는 곡면을 형성하도록 구성되는 것을 특징으로 하는 광 치료장치.The plate comprising the plurality of first light sources and the second light source is configured to form a curved surface.
  15. 다수개의 엘이디 광원을 구비하는 광 치료장치의 제어방법에 있어서,In the control method of a phototherapy device having a plurality of LED light source,
    가시광 영역의 파장을 갖는 광을 조사하는 제1 광원을 구동하는 단계;Driving a first light source for irradiating light having a wavelength in the visible light region;
    상기 제1 광원을 조사한 후, 근적외선 영역의 파장을 갖는 광을 조사하는 제2 광원을 구동하는 단계를 포함하는 광 치료장치의 제어방법.And driving a second light source for irradiating light having a wavelength in a near infrared region after irradiating the first light source.
  16. 제15항에 있어서,The method of claim 15,
    상기 제1 광원은 상기 제2 광원보다 피부 침투성이 낮은 파장의 광을 조사하는 것을 특징으로 하는 광 치료장치의 제어방법.And the first light source irradiates light having a wavelength lower than that of the second light source.
  17. 제16항에 있어서,The method of claim 16,
    상기 제1 광원은 600nm 이하의 파장의 광을 조사하고, 상기 제2 광원은 750nm 이상의 광을 조사하는 것을 특징으로 하는 광 치료장치의 제어방법.The first light source is irradiated with light of a wavelength of 600nm or less, the second light source is a control method of a phototherapy device, characterized in that for irradiating light 750nm or more.
  18. 제15항에 있어서,The method of claim 15,
    상기 제1 광원은 상기 제2 광원 대비 10% 이하의 출력으로 광을 조사하는 것을 특징으로 하는 광 치료장치의 제어방법.The first light source is a control method of the phototherapy device, characterized in that for irradiating light with an output of 10% or less than the second light source.
  19. 제15항에 있어서,The method of claim 15,
    상기 제1 광원을 구동하는 단계는 상기 제1 광원을 반복적으로 점멸하는 패턴으로 광을 조사하고, 상기 제2 광원을 구동하는 상기 제2 광원을 기 설정된 시간동안 연속적으로 점등하여 광을 조사하는 것을 특징으로 하는 광 치료장치의 제어방법.The driving of the first light source may be performed by irradiating light in a pattern in which the first light source is repeatedly flickering and irradiating light by continuously lighting the second light source driving the second light source for a predetermined time. Method for controlling the phototherapy device.
  20. 제15항에 있어서,The method of claim 15,
    상기 제2 광원을 구동하는 단계가 진행되는 동안 상기 제1 광원을 구동하는 단계를 지속적으로 진행하는 것을 특징으로 하는 광 치료장치의 제어방법.And controlling the driving of the first light source while the driving of the second light source is ongoing.
  21. 광 치료장치를 이용한 치료 방법에 있어서,In the treatment method using a light therapy device,
    제1 광원을 조사하여 치료 부위의 표피 조직을 활성화시키는 예비 치료단계; 그리고,A preliminary treatment step of activating epidermal tissue at the treatment site by irradiating a first light source; And,
    제2 광원을 조사하여 상기 치료 부위의 진피 조직을 활성화시켜 치료를 진행하는 본 치료 단계를 포함하고,Including the present treatment step of irradiating a second light source to activate the dermal tissue of the treatment site to proceed with the treatment,
    상기 제2 광원은 상기 제1 광원보다 피부 침투성이 우수한 파장의 광을 조사하는 것을 특징으로 하는 광 치료장치를 이용한 치료방법.The second light source is a treatment method using a phototherapy device, characterized in that for irradiating light of a wavelength superior to the skin penetration property than the first light source.
  22. 제21항에 있어서,The method of claim 21,
    상기 제1 광원은 표피층 또는 표피-진피 접합부(demal-epidermal junction)와 인접한 진피의 최상층에 흡수되는 광을 조사하고, 상기 제2 광원은 진피층에 흡수되는 광을 조사하는 것을 특징으로 하는 광 치료장치를 이용한 치료방법.Wherein the first light source irradiates light absorbed by the epidermal layer or the uppermost layer of the dermis adjacent to the epidermal-epidermal junction, and the second light source irradiates light absorbed by the dermal layer. Treatment method using.
  23. 제21항에 있어서,The method of claim 21,
    상기 제1 광원은 표피층에 위치하는 케라티노사이트(keratinocyte), 머르켈 세포(Merkel cell) 또는 랑게르한스 세포(Langerhans cell)를 활성화시키는 파장의 광을 조사하는 것을 특징으로 하는 광 치료장치를 이용한 치료방법.The first light source is a treatment method using a phototherapy device, characterized in that for irradiating the light of the wavelength activating keratinocyte (Keratinocyte), Merkel cells (Langerhans cell) located in the epidermal layer .
  24. 제21항에 있어서,The method of claim 21,
    상기 예비 치료 단계는 상기 제1 광원의 광에 의해 활성화된 표피층의 조직으로부터 세포 분비물질 또는 신경 전달물질이 분비되어 진피층으로 제공되는 것을 특징으로 하는 광 치료장치를 이용한 치료방법.In the preliminary treatment step, a cell secreting material or a neurotransmitter is secreted from the tissue of the epidermal layer activated by the light of the first light source and provided to the dermal layer.
PCT/KR2011/009832 2010-12-20 2011-12-20 Light therapy apparatus and method for controlling same WO2012086991A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0130510 2010-12-20
KR20100130510 2010-12-20

Publications (2)

Publication Number Publication Date
WO2012086991A2 true WO2012086991A2 (en) 2012-06-28
WO2012086991A3 WO2012086991A3 (en) 2012-09-07

Family

ID=46314605

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/009832 WO2012086991A2 (en) 2010-12-20 2011-12-20 Light therapy apparatus and method for controlling same

Country Status (2)

Country Link
KR (4) KR20120069588A (en)
WO (1) WO2012086991A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014064075A1 (en) 2012-10-23 2014-05-01 L'oreal Device, apparatus and method for cosmetic treatment by light
US10173072B2 (en) 2012-10-23 2019-01-08 L'oreal Device and method for cosmetic treatment by light
CN109173072A (en) * 2018-08-24 2019-01-11 重庆半岛医疗科技有限公司 A kind of phototherapy treatment device
CN114191722A (en) * 2021-11-30 2022-03-18 固安翌光科技有限公司 Flexible phototherapy device and bandage for wound treatment

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101598665B1 (en) * 2013-09-23 2016-02-29 박행배 The light therapy by skin improvement and hair restore device
KR101997115B1 (en) * 2018-01-10 2019-07-05 조선대학교산학협력단 Light irradiation system for skin and method of controlling light irradiation system for skin
KR101942547B1 (en) * 2018-04-13 2019-01-25 주식회사 휴라이트 Low-Level Laser therapeutic- apparatus
US20200298016A1 (en) * 2019-03-19 2020-09-24 Seoul Viosys Co., Ltd. Light irradiation device
WO2020190102A1 (en) * 2019-03-21 2020-09-24 서울바이오시스 주식회사 Light irradiation device
KR102380858B1 (en) * 2020-04-22 2022-04-01 한국생산기술연구원 Led helmet for hair loss treatment and its led placement method
KR20220125789A (en) * 2022-06-20 2022-09-14 (주)제이엔엠파트너스 Skin care device and system using galvanic current

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070002795A (en) * 2005-06-30 2007-01-05 서울반도체 주식회사 Medical treatment apparatus using rays of light
KR20080094642A (en) * 2008-09-25 2008-10-23 양원 Chair type light therapeutic device on meridian
JP2009525769A (en) * 2006-02-06 2009-07-16 ファロス ライフ コーポレイション Therapeutic devices, systems, and methods for reducing harmful exposure to electromagnetic radiation
KR20100066605A (en) * 2008-12-10 2010-06-18 한국전기연구원 Apparatus for photodynamic therapy and photo detection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080092068A (en) 2007-04-11 2008-10-15 곽종민 Skin therapy apparatus using light

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070002795A (en) * 2005-06-30 2007-01-05 서울반도체 주식회사 Medical treatment apparatus using rays of light
JP2009525769A (en) * 2006-02-06 2009-07-16 ファロス ライフ コーポレイション Therapeutic devices, systems, and methods for reducing harmful exposure to electromagnetic radiation
KR20080094642A (en) * 2008-09-25 2008-10-23 양원 Chair type light therapeutic device on meridian
KR20100066605A (en) * 2008-12-10 2010-06-18 한국전기연구원 Apparatus for photodynamic therapy and photo detection

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014064075A1 (en) 2012-10-23 2014-05-01 L'oreal Device, apparatus and method for cosmetic treatment by light
US10173072B2 (en) 2012-10-23 2019-01-08 L'oreal Device and method for cosmetic treatment by light
CN109173072A (en) * 2018-08-24 2019-01-11 重庆半岛医疗科技有限公司 A kind of phototherapy treatment device
CN114191722A (en) * 2021-11-30 2022-03-18 固安翌光科技有限公司 Flexible phototherapy device and bandage for wound treatment
CN114191722B (en) * 2021-11-30 2023-10-13 固安翌光科技有限公司 Flexible phototherapy device and bandage for wound treatment

Also Published As

Publication number Publication date
WO2012086991A3 (en) 2012-09-07
KR20120069588A (en) 2012-06-28
KR20140072854A (en) 2014-06-13
KR101845073B1 (en) 2018-04-03
KR20190046741A (en) 2019-05-07
KR20180037156A (en) 2018-04-11

Similar Documents

Publication Publication Date Title
WO2012086991A2 (en) Light therapy apparatus and method for controlling same
US10744340B2 (en) Capsule with whole body LED photo-therapy
US9486284B2 (en) Laser therapy system with UVA and IR laser light for directional generation of a dermal collagen matrix
JP2006519047A (en) Beauty or treatment method and apparatus
KR100839022B1 (en) Medical led cure device radiating multi wave
DE59209638D1 (en) DEVICE FOR PHOTODYNAMIC ENERGY SIMULATION
WO2014193029A1 (en) Skin treatment laser irradiation apparatus and skin treatment laser irradiation method using same
WO2008108774A1 (en) Light therapy bandage with imbedded emitters
CN101316624A (en) Light therapy apparatus
JP2013532503A (en) Disposable skin care equipment
WO2020190022A1 (en) Light emission device
JP2010505566A (en) Dermatological treatment device
WO2019124914A1 (en) Light therapy device and method for controlling same
WO2014021557A1 (en) A nasal cavity treatment irradiation apparatus
US20200108268A1 (en) Photo-therapeutic method and apparatus
CN104888361B (en) A kind of two-sided Icterus treatment equipment of energy accurate temperature controlling
JP6082532B2 (en) Phototherapy device
KR880001155B1 (en) The curing device of athlete's foot
WO2018199578A1 (en) Laser device for dermal therapy
JP2012016438A (en) Apparatus for treating user's skin
EP1183072B1 (en) Tissue rejuvenation by illuminating radiation
WO2020213909A1 (en) Fingernail steamer having sterilizing lamp
KR20170042173A (en) Multi-wavelength LED light treatment device including an oxygen generator for generating a high concentration of oxygen
TW201331520A (en) Photostimulation method and device with light mixture
CN108434607A (en) A kind of beauty instrument and its application method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11849986

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11849986

Country of ref document: EP

Kind code of ref document: A2